Australian Shares Sparty's Blog
Comments on this blog should never be taken as investment advice
Posts on this website are general "tips" and nothing more than that and should never be used to make an investment or trading decision. All information should be carefully cross-checked against official sources for accuracy. Sparty's posts nearly always relate to companies that he either holds, has held or intends to hold.
Main Forum•ASX MMJ CBD Microcapsules in all pharmaceutical outlets in Germany
-
Satipharm Sales Update and Expansion of European Distribution Network: 13 March 2017
- Satipharm’s flagship product, Gelpell-CBD Microgel Capsules, now available for sale throughout all pharmaceutical outlets in Germany
- Strategic partnership with online pharmaceutical reseller enables shipping of Satipharm products globally – removing significant payment gateway issues
- European sales footprint further expanded following signing of binding LOI with one of the fastest growing pharmaceutical distributors in Denmark
- MMJ to work with distribution partners to roll out strategic sales and marketing campaign across Europe aimed at boosting brand awareness and product sales